- Home
- SYRE vs PRVA Comparison
SYRE vs PRVA Comparison
Compare SYRE & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | PRVA |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SYRE | PRVA |
|---|---|---|
| Price | $34.16 | $21.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $56.50 | $30.50 |
| AVG Volume (30 Days) | 569.5K | ★ 753.7K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $2,042,569,000.00 |
| Revenue This Year | N/A | $23.19 |
| Revenue Next Year | N/A | $13.51 |
| P/E Ratio | ★ N/A | $153.56 |
| Revenue Growth | N/A | ★ 19.01 |
| 52 Week Low | $10.91 | $18.77 |
| 52 Week High | $35.31 | $26.51 |
Technical Indicators
Market Signals| Indicator | SYRE | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 32.37 |
| Support Level | $30.92 | $21.36 |
| Resistance Level | $34.07 | $22.70 |
| Average True Range (ATR) | 1.80 | 0.88 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 78.41 | 0.35 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.